Abstract
We present the genotype/phenotype correlation analysis for 16 cystic fibrosis (CF) patients who carry mutation R334W. Current age and age of diagnosis was significantly higher in the R334W/any-mutation group (P < 0.05 and P < 0.01), compared with the Δ508/Δ508 group. A slightly, but not significantly, worse lung function was found in the R334W/any-mutation group, when compared with the Δ508/Δ508 patients. The proportion of patients with lung colonization with bacterial pathogens was slightly, but not significantly, higher in the R334W/any-mutation group (71.4%), compared with the Δ508/Δ508 or R334W/Δ508 groups (55.5%). None of the R334W patients had meconium ileus but 60% were pancreatic insufficient (PI), a significantly lower proportion (P ≪ 0.001) than Δ508/Δ508 patients. Two R334W/N1303K compound heterozygous sisters were PI but discrepant for lung function. Two groups of three sibs with genotype R334W/Δ508 showed interfamilial discordant clinical data for lung and pancreatic function. The data provided here for mutation R334W demonstrate that this mutation is responsible for a less severe form of CF than Δ508. Interfamilial differences for PI and lung function suggest that other factors, viz. genetic, environmental and medical, contribute to the wide spectrum of clinical differences observed in CF patients with the same CF transmembrane conductance regulator genotypes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson MP, Rich DP, Gregory RJ, Smith AE, Welsh MJ (1990) Generation of cAMP-activated chloride currents by expression of CFTR. Science 251:679–682
Bear CE, Canhui L, Kartner N, Bridges RJ, Jense TJ, Ramjessingh M, Riordan JR (1992) Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68:809–818
Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. In: McGraw Hill, New York, pp 2649–2680
Borgo G, Mastella G, Gasparini P, Zorzanello A, Doro R, Pignatti PF (1990) Pancreatic function and gene deletion F508 in cystic fibrosis. J Med Genet 27:665–669
Campbell PW III, Philips JA III, Krishnamani MR, Maness KJ, Hazinski TA (1991) Cystic fibrosis: relationship between clinical status and F508 deletion. J Pediatr 118:239–241
Cheng S, Gregory R, Marshall J, Paul S, Souza D, White G, O'Riordan C, et al (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63:827–834
Chevalier-Porst F, Bonardot AM, Gilly R, Chazalette JP, Mathieu M, Bozon D (1994) Mutation analysis in 600 French cystic fibrosis patients. J Med Genet 31:541–544
Chillón M, Casals T, Nunes V, Giménez J, Pérez Ruiz E, Estivill X (1993) Identification of a new missense mutation (P205S) in the first transmembrane domain of the CFTR gene associated with a mild cystic fibrosis phenotype. Hum Mol Genet 10:1741–1742
Chillón M, Casals T, Giménez J, Nunes V, Estivill X (1994a) Analysis of the CFTR gene in the Spanish population: SSCP-screening for 60 known mutations and identification of four new mutations (Q30X, A120T, 1812–1G→A and 3667del4). Hum Mutat 3:223–230
Chillón M, Casals T, Giménez J, Ramos MD, Palacio A, Morral N, Estivill X, Nunes V (1994b) Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes. Hum Genet 93:447–451
Dean M, White M, Amos J, Gerrard B, Stewart C, Khaw KT, Leppert M (1990) Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell 61:863–870
Gasparini P, Nunes V, Savoia A, Dognini M, Morral N, Gaona A, Bonizzato A, Chillón M, Sangiulo F, Novelli G, Dallapiccola B, Pignatti PF, Estivill X (1991) The search for south European cystic fibrosis mutations: identification of two new mutations, four variants and intronic sequences. Genomics 10:193–200
Gasparini P, Borgo G, Mastella G, Bonizzato A, Dognini M, Pignatti PF (1992) Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease. J Med Genet 29:558–562
Gregory RJ, Cheng SH, Rich DP, Marshall J, Paul S, Hehir K, Ostedgaard L, et al (1990) Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347:382–386
Hamosh A, King TM, Rosenstein BJ, Corey M, Levison H, Durie P, Tsui L-C, MacIntosh I, et al (1992) Cystic fibrosis patients bearing both the common missense mutation Gly→Asp at codon 551 and the Δ508 mutation are clinically indistinguishable from Δ508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet 51:245–250
Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M (1991) Severity of cystic fibrosis in patients homozygous and heterozygous for the Δ508 mutation. Lancet 337:631–634
Kartner N, Hanrahan JW, Jensen TJ, Naismith AL, Sun S, Ackerley CA, Reyes EF, et al (1991) Expression of the cystic fibrosis gene in non epithelial invertebrate cells produces a regulated anion conductance. Cell 64:681–691
Kerem B, Rommens JM, Buchanan JA, Markiewicz DA, Cox TK, Chakravarti A, Buchwald M, Tsui L-C (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Kerem E, Corey M, Kerem B-S, Rommens J, Markiewicz D, Levinson H, Tsui L-C, et al (1990) The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (Δ508). N Engl J Med 323:1517–1522
Kristidis P, Bozon D, Corey M, et al (1992) Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 50:1178–1184
Liechti-Gallati S, Bonsall I, Malik N, et al (1992) Genotype/ phenotype association in cystic fibrosis: analysis of the Δ508, R553X and 3905insT mutations. Pediatr Res 32:175–178
Morral N, Estivill X (1992) Multiplex PCR amplification of three microsatellites within the CFTR gene. Genomics 13:1362–1364
Morral N, Nunes V, Casals T, et al (1993) Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers. Hum Mol Genet 2:1015–1022
Morral N, Llevadot R, Casals T, et al (1994) Independent origin of cystic fibrosis mutations R334W, R347P, R1162X, and 3849+10kbC→T provide evidence of mutation recurrence in the CFTR gene. Am J Hum Genet 55:890–898
Nunes V, Casals T, Gaona A, Antiñolo G, Ferrer-Calvete J, Pérez-Frías J, Tardío E, Molano J, Estivill X (1992) Cystic fibrosis patients with mutation 1949del84 in exon 13 of the CFTR gene have a similar clinical severity as Δ508 homozygotes. Hum Mut l:375–379
Nunes V, Chillón M, Dörk T, Tümmler B, Casals T, Estivill X (1993) A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype. Hum Mol Genet 1:79–80
Osborne L, Santis G, Schwarz M, Klinger K, Dörk T, MacIntosh I, Schwartz M, Nunes V, et al (1992) Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum Genet 89:653–658
Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of the complementary DNA. Science 245:1066–1072
Santis G, Osborne L, Knight RA, Hodson ME (1990) Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 336:1081–184
Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ (1993) Mutations in CFTR associated with mild-disease from Cl-channels with altered pore properties. Nature 362:160–164
Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, Tal A, Seret H, et al (1992) Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 50:222–228
The Cystic Fibrosis Genotype/Phenotype Consortium (1993) Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 28:1308–1313
The Cystic Fibrosis Analysis Consortium (1994) Population variation of common CF mutations. Hum Mutat 4:167–177
Tsui L-C (1992a) The spectrum of cystic fibrosis mutations. Trends Genet 8:392–398
Tsui L-C (1992b) Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat 1:197–203
Welsh MJ, Smith AE (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251–1254
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Estivill, X., Llevadot, R., Giménez, J. et al. Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences. Hum Genet 95, 331–336 (1995). https://doi.org/10.1007/BF00225203
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00225203